The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

Despite a 5% revenue increase, Vanda Pharmaceuticals Inc (VNDA) faces challenges with a significant net loss and rising operating expenses. WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.